Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.75 USD | -2.72% | -2.86% | -34.18% |
07/05 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
07/05 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.18% | 249.93Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-2.24% | 2.2TCr | |
-14.15% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Moonlake Immunotherapeutics Insider Sold Shares Worth $6,803,044, According to a Recent SEC Filing